A conserved mechanism for binding of p53 DNA-binding domain and anti-apoptotic Bcl-2 family proteins

Molecules and Cells

Volumn 37, Issue 3, 2014, Pages 264-269

  Lee, Dong Hwa ^a   Ha, Ji Hyang ^a   Kim, Yul ^b   Jang, Mi ^a   Park, Sung Jean ^c   Yoon, Ho Sup ^d   Kim, Eun Hee ^e   Bae, Kwang Hee ^a   Park, Byoung Chul ^a   Park, Sung Goo ^a   Yi, Gwan Su ^b   Chi, Seung Wook ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^c Gachon University   (South Korea)

^d NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^e Korea Basic Science Institute (KBSI)   (South Korea)

Author keywords

Apoptosis; Bcl 2 family proteins; Binding mechanism; DNA binding domain; p53

Indexed keywords

PROTEIN BCL 2; PROTEIN BCL W; PROTEIN BCL XL; PROTEIN MCL 1; PROTEIN P53; APOPTOSIS REGULATORY PROTEIN; BCL2L2 PROTEIN, HUMAN; MCL1 PROTEIN, HUMAN; MYELOID LEUKEMIA FACTOR 1; PROTEIN BINDING; TP53 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CONFORMATIONAL TRANSITION; HUMAN; HUMAN CELL; PROTEIN DNA BINDING; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; ALLOSTERISM; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; NUCLEAR MAGNETIC RESONANCE; PEPTIDE MAPPING; PHYSIOLOGY; PROTEIN DOMAIN; PROTEIN QUATERNARY STRUCTURE; PROTEIN SECONDARY STRUCTURE;

ALLOSTERIC REGULATION; APOPTOSIS REGULATORY PROTEINS; CELL LINE; HUMANS; MODELS, MOLECULAR; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDE MAPPING; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84896923814     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.14348/molcells.2014.0001     Document Type: Article

References (46)

1. Adams, J.M., and Cory, S. (1998). The Bcl-2 protein family: arbiters of cell survival. Science (New York, N.Y) 281, 1322-1326. (Pubitemid 28406819)
2. Adams, J.M., and Cory, S. (2007). The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26, 1324-1337. (Pubitemid 46328466)
3. Brown, C.J., Lain, S., Verma, C.S., Fersht, A.R., and Lane, D.P. (2009). Awakening guardian angels: drugging the p53 pathway. Nat. Rev. 9, 862-873.
4. Chen, R., Li, L., and Weng, Z. (2003). ZDOCK: an initial-stage protein-docking algorithm. Proteins 52, 80-87. (Pubitemid 36648854)
5. Chi, S.W. (2014). Structural insights into the transcription-independent apoptotic pathway of p53. BMB Rep. pii: 2593. [Epub ahead of print]
6. Chipuk, J.E., Kuwana, T., Bouchier-Hayes, L., Droin, N.M., Newmeyer, D.D., Schuler, M., and Green, D.R. (2004). Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303, 1010-1014. (Pubitemid 38209704)
7. Chipuk, J.E., Bouchier-Hayes, L., Kuwana, T., Newmeyer, D.D., and Green, D.R. (2005). PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 309, 1732-1735. (Pubitemid 41285944)
8. Czabotar, P.E., Lee, E.F., van Delft, M.F., Day, C.L., Smith, B.J., Huang, D.C., Fairlie, W.D., Hinds, M.G., and Colman, P.M. (2007). Structural insights into the degradation of Mcl-1 induced by BH3 domains. Proc. Natl. Acad. Sci. USA 104, 6217-6222. (Pubitemid 47186075)
9. Danial, N.N. (2007). BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clin. Cancer Res. 13, 7254-7263.
10. Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J., and Bax, A. (1995). NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277-293.
11. DeLano, W.L. (2002). The PyMOL Molecular Graphics System; in PyMOL (DeLano Scientific).
12. Denisov, A.Y., Madiraju, M.S., Chen, G., Khadir, A., Beauparlant, P., Attardo, G., Shore, G.C., and Gehring, K. (2003). Solution structure of human BCL-w: modulation of ligand binding by the C-terminal helix. J. Biol. Chem. 278, 21124-21128. (Pubitemid 36806425)
13. Ding, X., Yang, Z., Zhou, F., Hu, X., Zhou, C., Luo, C., He, Z., Liu, Q., Li, H., Yan, F., et al. (2012). Human intersectin 2 (ITSN2) binds to Eps8 protein and enhances its degradation. BMB Rep. 45, 183-188.
14. Fesik, S.W. (2005). Promoting apoptosis as a strategy for cancer drug discovery. Nat. Rev. 5, 876-885.
15. Green, D.R., and Kroemer, G. (2009). Cytoplasmic functions of the tumour suppressor p53. Nature 458, 1127-1130.
16. Ha, J., Won, E., Yoon, H., Kang, S., Bae, K., Park, S., Park, B., Choi, B., Lee, J., and Chi, S. (2009). Molecular Interaction between a Bcl-2 homolog from Kaposi sarcoma virus and p53. Bull. Korean Chem. Soc. 30, 1655.
17. Ha, J.H., Won, E.Y., Shin, J.S., Jang, M., Ryu, K.S., Bae, K.H., Park, S.G., Park, B.C., Yoon, H.S., and Chi, S.W. (2011). Molecular mimicry-based repositioning of nutlin-3 to anti-apoptotic Bcl-2 family proteins. J. Am. Chem. Soc. 133, 1244-1247.
18. Ha, J.H., Shin, J.S., Yoon, M.K., Lee, M.S., He, F., Bae, K.H., Yoon, H.S., Lee, C.K., Park, S.G., Muto, Y., et al. (2013). Dual-site interactions of p53 protein transactivation domain with antiapoptotic Bcl-2 family proteins reveal a highly convergent mechanism of divergent p53 pathways. J. Biol. Chem. 288, 7387-7398.
19. Hagn, F., Klein, C., Demmer, O., Marchenko, N., Vaseva, A., Moll, U.M., and Kessler, H. (2010). BclxL changes conformation upon binding to wild-type but not mutant p53 DNA binding domain. J. Biol. Chem. 285, 3439-3450.
20. Harris, S.L., and Levine, A.J. (2005). The p53 pathway: positive and negative feedback loops. Oncogene 24, 2899-2908. (Pubitemid 40638098)
21. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C.C. (1991). p53 mutations in human cancers. Science (New York, N.Y) 253, 49-53. (Pubitemid 21917115)
22. Jiang, P., Du, W., Heese, K., and Wu, M. (2006). The Bad guy cooperates with good cop p53: Bad is transcriptionally up-regulated by p53 and forms a Bad/p53 complex at the mitochondria to induce apoptosis. Mol. Cell Biol. 26, 9071-9082. (Pubitemid 44851962)
23. Lee, D.H., Ha, J.H., Kim, Y., Bae, K.H., Park, J.Y., Choi, W.S., Yoon, H.S., Park, S.G., Park, B.C., Yi, G.S., et al. (2011). Interaction of a putative BH3 domain of clusterin with anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy. Biochem. Biophys. Res. Commun. 408, 541-547.
24. Lessene, G., Czabotar, P.E., and Colman, P.M. (2008). BCL-2 family antagonists for cancer therapy. Nat. Rev. Drug Discov. 7, 989-1000.
25. Leu, J.I., Dumont, P., Hafey, M., Murphy, M.E., and George, D.L. (2004). Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat. Cell Biol. 6, 443-450. (Pubitemid 38607505)
26. Matissek, K.J., Mossalam, M., Okal, A., and Lim, C.S. (2013). The DNA binding domain of p53 is sufficient to trigger a potent apoptotic response at the mitochondria. Mol. Pharm. 10, 3592-3602.
27. Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., and Moll, U.M. (2003). p53 has a direct apoptogenic role at the mitochondria. Mol. Cell 11, 577-590. (Pubitemid 36385115)
28. Moll, U.M., Wolff, S., Speidel, D., and Deppert, W. (2005). Transcription-independent pro-apoptotic functions of p53. Curr. Opin. Cell Biol. 17, 631-636. (Pubitemid 41540413)
29. Petros, A.M., Medek, A., Nettesheim, D.G., Kim, D.H., Yoon, H.S., Swift, K., Matayoshi, E.D., Oltersdorf, T., and Fesik, S.W. (2001). Solution structure of the antiapoptotic protein bcl-2. Proc. Natl. Acad. Sci. USA 98, 3012-3017. (Pubitemid 32220791)
30. Petros, A.M., Olejniczak, E.T., and Fesik, S.W. (2004). Structural biology of the Bcl-2 family of proteins. Biochim. Biophys. Acta 1644, 83-94. (Pubitemid 38281265)
31. Rajagopalan, S., Andreeva, A., Rutherford, T.J., and Fersht, A.R. (2010). Mapping the physical and functional interactions between the tumor suppressors p53 and BRCA2. Proc. Natl. Acad. Sci. USA 107, 8587-8592.
32. Shin, J.S., Ha, J.H., He, F., Muto, Y., Ryu, K.S., Yoon, H.S., Kang, S., Park, S.G., Park, B.C., Choi, S.U., et al. (2012). Structural insights into the dual-targeting mechanism of Nutlin-3. Biochem. Biophys. Res. Commun. 420, 48-53.
33. Shin, J.S., Ha, J.H., and Chi, S.W. (2013). Targeting of p53 peptide analogues to anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy. Biochem. Biophys. Res. Commun. 443, 882-887.
34. Sot, B., Freund, S.M., and Fersht, A.R. (2007). Comparative biophysical characterization of p53 with the pro-apoptotic BAK and the anti-apoptotic BCL-xL. J. Biol. Chem. 282, 29193-29200. (Pubitemid 350043367)
35. Stoll, R., Renner, C., Hansen, S., Palme, S., Klein, C., Belling, A., Zeslawski, W., Kamionka, M., Rehm, T., Muhlhahn, P., et al. (2001). Chalcone derivatives antagonize interactions between the human oncoprotein MDM2 and p53. Biochemistry 40, 336-344. (Pubitemid 32061981)
36. Tomita, Y., Marchenko, N., Erster, S., Nemajerova, A., Dehner, A., Klein, C., Pan, H., Kessler, H., Pancoska, P., and Moll, U.M. (2006). WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J. Biol. Chem. 281, 8600-8606. (Pubitemid 43847963)
37. Vaseva, A.V., and Moll, U.M. (2009). The mitochondrial p53 pathway. Biochim. Biophys. Acta 1787, 414-420.
38. Vogelstein, B., Lane, D., and Levine, A.J. (2000). Surfing the p53 network. Nature 408, 307-310.
39. Vousden, K.H., and Lu, X. (2002). Live or let die: the cell's response to p53. Nat. Rev. Cancer 2, 594-604. (Pubitemid 37328926)
40. Wang, R., Shen, J., Huang, P., and Zhu, X. (2013). CCCTC-binding factor controls its own nuclear transport via regulating the expression of importin 13. Mol. Cells 35, 388-395.
41. Wong, K.B., DeDecker, B.S., Freund, S.M., Proctor, M.R., Bycroft, M., and Fersht, A.R. (1999). Hot-spot mutants of p53 core domain evince characteristic local structural changes. Proc. Natl. Acad. Sci. USA 96, 8438-8442. (Pubitemid 29354809)
42. Xu, H., Ye, H., Osman, N.E., Sadler, K., Won, E.Y., Chi, S.W., and Yoon, H.S. (2009). The MDM2-binding region in the transactivation domain of p53 also acts as a Bcl-X(L)-binding motif. Biochemistry 48, 12159-12168.
43. Yao, H., Mi, S., Gong, W., Lin, J., Xu, N., Perrett, S., Xia, B., Wang, J., and Feng, Y. (2013). Anti-apoptosis proteins Mcl-1 and Bcl-xL have different p53-binding profiles. Biochemistry 52, 6324-6334.
44. Yoon, I.S., Chung, J.H., Hahm, S.H., Park, M.J., Lee, Y.R., Ko, S.I., Kang, L.W., Kim, T.S., Kim, J., and Han, Y.S. (2011). Ribosomal protein S3 is phosphorylated by Cdk1/cdc2 during G2/M phase. BMB Rep. 44, 529-534.
45. Youle, R.J., and Strasser, A. (2008). The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9, 47-59.
46. Yu, G.W., Rudiger, S., Veprintsev, D., Freund, S., Fernandez-Fernandez, M.R., and Fersht, A.R. (2006). The central region of HDM2 provides a second binding site for p53. Proc. Natl. Acad. Sci. USA 103, 1227-1232. (Pubitemid 43191147)